ERAS

Healthcaremid cap
QNTM SCORE
31/100
LOW CONVICTION
top 94% of the universe

As of 2026-07-28, ERAS scores 31out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. ERAS trades at $18.09, within its fair-value band.

FACTOR BREAKDOWN

Momentum54
Quality23
Value0
Volume45
Sentiment38

VALUATION RANGE

QNTM’s descriptive fair-value band for ERAS runs $9.54–$19.80. Current price $18.09 sits within its fair-value band. This is valuation context, not a price target.

See ERAS update live, and set an alert when its conviction changes

QNTM rescores ERAS and ~1,400 other names every session. Track it, get notified the moment it crosses a conviction tier, and see the full signal history.

Start free →

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-07-28.

ERAS Quant Score, Factor Analysis & Conviction | QNTM